Cardiac Safety Service Market Size, Share and Forecast Trends - Growth Analysis and Outlook Report 2026-2030

The cardiac safety services market covers specialized ECG, Holter, blood pressure, and thorough QT studies outsourced to CROs and cardiac safety laboratories that support clinical trial sponsors. The market was valued at approximately USD 1.01 billion in 2025 and is forecast to grow at a compound annual rate of around 12.0% through the early 2030s. ECG and Holter-based cardiac monitoring remain the dominant service categories, while thorough QT and cardiac telemetry services are gaining share as protocols become more rigorous.

• •Market size in 2025: ~USD 1.01 billion, expanding at ~12.0% CAGR
• •Core services: ECG/Holter measurement, blood pressure monitoring, thorough QT studies, cardiac telemetry
• •Demand driven by pharma, biotech, and medical device clinical trial sponsors

Stricter regulatory expectations around cardiovascular safety, particularly QT prolongation and arrhythmia risk, are pushing sponsors to include more intensive cardiac monitoring in trial protocols. A growing global clinical trial pipeline, especially in cardiovascular, oncology, and metabolic indications, is expanding the addressable patient and site base for cardiac safety work. Outsourcing to specialized providers is also rising as sponsors seek to reduce capital investment in core ECG laboratories.

• •Heightened regulatory focus on QT prolongation and pro-arrhythmic risk
• •Rising number of global clinical trials and increasing protocol complexity
• •Greater outsourcing of cardiac safety operations from sponsors to CROs

By service type, the market splits between integrated and standalone cardiac safety offerings, with integrated services capturing a larger share as sponsors prefer end-to-end providers. Geographically, North America leads due to high clinical trial activity, dense CRO infrastructure, and FDA-driven safety expectations, while Asia-Pacific is the fastest-growing region as trials migrate to China, India, and other emerging hubs. Europe maintains a significant share supported by EMA-aligned safety standards and a strong CRO presence.

• •Service split: integrated services dominate; standalone services serve niche requirements
• •North America holds the largest share; Asia-Pacific is the fastest-growing region
• •Europe remains a meaningful market on the back of EMA-driven standards

What are the recent trends and outlook?

Adoption of continuous cardiac telemetry and wearable ECG sensors is reshaping data collection, allowing higher-fidelity Holter and ambulatory monitoring across decentralized and hybrid trial designs. Artificial intelligence is being layered onto ECG interpretation and arrhythmia detection to accelerate read turnaround and standardize analysis across global sites. With strong regulatory tailwinds and double-digit growth, the market is expected to remain on a steep expansion trajectory through the early 2030s.

• •Wearable and continuous telemetry ECG adoption is rising across decentralized trials
• •AI-assisted ECG interpretation is improving speed and consistency of reads
• •Outlook: sustained double-digit growth as cardiac safety becomes a standard component of clinical development